Upcoming Expiry of Listed Options (ATHO) MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 29 July 2026 : Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative...